Related references
Note: Only part of the references are listed.Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues
John R. Hawse et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Interaction Proteomics Identifies ERbeta Association with Chromatin Repressive Complexes to Inhibit Cholesterol Biosynthesis and Exert An Oncosuppressive Role in Triple-negative Breast Cancer
Elena Alexandrova et al.
MOLECULAR & CELLULAR PROTEOMICS (2020)
The functional activity of E-cadherin controls tumor cell metastasis at multiple steps
Tae-Young Na et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Insights into the Role of Estrogen Receptor beta in Triple-Negative Breast Cancer
Assunta Sellitto et al.
CANCERS (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Analogues of ERβ ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosis
Hawra Karim et al.
SCIENTIFIC REPORTS (2019)
Update on ERbeta
Jan-Ake Gustafsson et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds
Yvonne Ziegler et al.
NPJ BREAST CANCER (2019)
TSVdb: a web-tool for TCGA splicing variants analysis
Wenjie Sun et al.
BMC GENOMICS (2018)
Differential Effects of Estrogen Receptor β Isoforms on Glioblastoma Progression
Jinyou Liu et al.
CANCER RESEARCH (2018)
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
L. Gerratana et al.
CANCER TREATMENT REVIEWS (2018)
Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer
Cameron N. Johnstone et al.
DISEASE MODELS & MECHANISMS (2018)
E-cadherin in contact inhibition and cancer
Alisha M. Mendonsa et al.
ONCOGENE (2018)
Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis
Linjie Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis
Jordan M. Reese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity
Adam W. Nelson et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Insufficient antibody validation challenges oestrogen receptor beta research
Sandra Andersson et al.
NATURE COMMUNICATIONS (2017)
Estrogen receptor beta 2 induces proliferation and invasiveness of triple negative breast cancer cells; association with regulation of PHD3 and HIF-1 alpha
Lucia Bialesova et al.
ONCOTARGET (2017)
MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression
Jessica L. Christenson et al.
HORMONES & CANCER (2017)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies
Xun Chen et al.
JOURNAL OF CANCER (2016)
Clinical implications of molecular heterogeneity in triple negative breast cancer
Brian D. Lehmann et al.
BREAST (2015)
Estrogen receptors in breast carcinogenesis and endocrine therapy
Bo Huang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis
Yuechao Zhao et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Targeting the Androgen Receptor in Breast Cancer
KeeMing Chia et al.
CURRENT ONCOLOGY REPORTS (2015)
ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
Jordan M. Reese et al.
BMC CANCER (2014)
Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures
Katherine Drews-Elger et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Multiple functional therapeutic effects of the estrogen receptor β agonist indazole-Cl in a mouse model of multiple sclerosis
Spencer M. Moore et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer
Bo Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential
Ilaria Paterni et al.
STEROIDS (2014)
The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells
Anna Bergamaschi et al.
BREAST CANCER RESEARCH (2014)
Mechanisms enforcing the estrogen receptor β selectivity of botanical estrogens
Yan Jiang et al.
FASEB JOURNAL (2013)
Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
Zeynep Madak-Erdogan et al.
MOLECULAR SYSTEMS BIOLOGY (2013)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
Activation of the Glucocorticoid Receptor Is Associated with Poor Prognosis in Estrogen Receptor-Negative Breast Cancer
Deng Pan et al.
CANCER RESEARCH (2011)
An ADIOL-ERβ-CtBP Transrepression Pathway Negatively Regulates Microglia-Mediated Inflammation
Kaoru Saijo et al.
CELL (2011)
Triple-Negative Breast Cancer: An Unmet Medical Need
Clifford A. Hudis et al.
ONCOLOGIST (2011)
E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases
L. Asnaghi et al.
ONCOGENE (2010)
Cystatins and cancer
James L. Cox
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Benzopyrans are selective estrogen receptor β agonists with novel activity in models of benign prostatic hyperplasia
Bryan H. Norman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Impact of estrogen receptor β on gene networks regulated by estrogen receptor α in breast cancer cells
Edmund C. Chang et al.
ENDOCRINOLOGY (2006)
Estrogen receptor (ER)-β isoforms:: A key to understanding ER-β signaling
Yuet-Kin Leung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Estrogen receptors beta4 and Beta5 are full length functionally distinct ERβ isoforms -: Cloning from human ovary and functional characterization
I Poola et al.
ENDOCRINE (2005)
Indazole estrogens:: Highly selective ligands for the estrogen receptor β
M De Angelis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Human estrogen receptor beta-specific monoclonal antibodies: characterization and use in studies of estrogen receptor beta protein expression in reproductive tissues
I Choi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Share Paper
